Review Comorbidities Across Functional Neurological Disorder Subtypes: A Comprehensive Narrative Synthesis 2025 Anton et al

Andy

Senior Member (Voting rights)

Abstract​

Background: Functional Neurological Disorder (FND) encompasses a spectrum of symptoms—including motor, cognitive, and seizure-like manifestations—that are not fully explained by structural neurological disease. Accumulating evidence suggests that comorbid psychiatric and somatic conditions significantly influence the clinical course, diagnostic complexity, and treatment response in FND.

Objective: This study systematically explores psychiatric and medical comorbidities across major FND subtypes—Functional Cognitive Disorder (FCD), Functional Movement Disorder (FMD), and Psychogenic Non-Epileptic Seizures (PNES)—with an emphasis on subtype-specific patterns and shared vulnerabilities.

Methods: We conducted a narrative review of the published literature, guided by systematic principles for transparency, covering both foundational and contemporary sources to examine comorbid conditions in patients with FCD, FMD, PNES, PPPD and general (mixed) FND populations. Relevant studies were identified through structured research and included based on methodological rigor and detailed reporting of comorbidities (PRISMA). Extracted data were organized by subtype and comorbidity type (psychiatric or medical/somatic).

Results: Across all FND subtypes, high rates of psychiatric comorbidities were observed, particularly depression, anxiety, PTSD, and dissociative symptoms. FCD was predominantly associated with internalizing symptoms, affective misattribution, and heightened cognitive self-monitoring. FMD demonstrated strong links with trauma, emotional dysregulation, and personality vulnerabilities. PNES was characterized by the highest burden of psychiatric illness, with complex trauma histories and dissociation frequently reported. Somatic comorbidities—such as fibromyalgia, chronic pain, irritable bowel syndrome, and fatigue—were also prevalent across all subtypes, reflecting overlapping mechanisms involving interoception, central sensitization, and functional symptom migration.

Conclusions: Comorbid psychiatric and medical conditions are integral to understanding the presentation and management of FND. Subtype-specific patterns underscore the need for individualized diagnostic and therapeutic approaches, while the shared biopsychosocial mechanisms suggest benefits of integrated care models across the FND spectrum.

Open access
 
What they say about fatigue and 'fatigue syndromes' in the paper.

"Somatic and pain-related comorbidities were discussed in 11 of the reviewed studies, focusing on chronic pain, fibromyalgia, fatigue syndromes, gastrointestinal disturbances, and functional sensory symptoms."

"Somatic and Pain Comorbidities

Somatic symptoms and chronic pain are central to the PNES and FMD comorbidity spectrum. Chronic pain, fibromyalgia, fatigue syndromes, and gastrointestinal disturbances are commonly reported in PNES, sometimes overshadowing seizure-like episodes and leading to diagnostic confusion [94]. FMD also demonstrates significant overlap with pain syndromes, including functional pain disorders and fatigue, particularly in patients with coexisting gait disturbances and dystonia."

"In the case of Functional Cognitive Disorder (FCD), psychiatric conditions, particularly anxiety disorders, depression, and health-related anxiety, frequently dominate the clinical picture. Our findings reveal that anxiety was present in over 48% of FCD cases, with depression and fatigue following closely. These comorbidities do not merely coexist with cognitive complaints but are deeply intertwined with the phenomenology of the disorder."

"Functional Movement Disorder (FMD) emerged in this study as the subtype most consistently associated with a high overall burden of comorbidities. Psychiatric comorbidities were strikingly prevalent, with depression present in over 70% of cases and anxiety exceeding 80% in several datasets. Early life trauma and adverse childhood experiences were also frequently reported, suggesting a significant role for stress and psychological vulnerability in shaping motor symptomatology [8]. Fatigue, chronic pain, and migraine were among the most common physical comorbidities."

"The presence of these symptoms may also impair engagement with rehabilitation, particularly when pain and fatigue reduce physical stamina or increase activity avoidance. Therefore, these findings underscore the importance of a personalized, interdisciplinary model of care that incorporates pain management, physiotherapy, psychological support, and trauma-informed intervention"

"Across all FND subtypes, our cluster and correlation analyses revealed frequent co-occurrence of specific comorbidities, such as the pairing of anxiety and depression, or fatigue and chronic pain [113,114]. These combinations often form distinct clinical phenotypes that transcend traditional subtype boundaries. Such comorbidity patterns have substantial implications for both diagnosis and treatment. Patients with high comorbidity burdens tend to experience longer symptom duration, increased functional impairment, and reduced responsiveness to single-modality interventions. Furthermore, comorbid conditions often shape how patients interpret their symptoms. For instance, individuals with fibromyalgia or chronic fatigue may interpret new neurological symptoms as further evidence of an organic or degenerative illness, thereby reinforce maladaptive illness beliefs and increasing resistance to the functional formulation."

"Clinicians must also remain vigilant for the risk of diagnostic overshadowing, where attention to comorbid psychiatric symptoms may lead to under-recognition of the functional neurological presentation, or conversely, where functional symptoms obscure serious coexisting medical conditions"

"In conclusion, functional neurological disorder (FND) reveals its complexity only when viewed through a biopsychosocial prism: biological predisposition, traumatic events and social context intertwine to generate a diverse range of clinical manifestations. Psychiatric comorbidities such as anxiety, depression and PTSD, as well as somatic comorbidities, chronic pain, fatigue or sleep disorders, are not simple coincidences, but active partners in the maintenance of functional symptoms. This subtle interaction explains why in psychogenic non-epileptic epilepsy, the burden of trauma often precedes seizures, why in functional motor disorders feelings of pain and exhaustion make the rehabilitation process difficult and why in functional cognitive disorders, cognitive anxiety amplifies the feeling of “mental fog” and the avoidance of challenging situations.

Across all subtypes, the high prevalence of psychiatric and somatic comorbidities is a defining feature of FND, with direct implications for prognosis and therapeutic planning. Their systematic identification should be considered a priority in both research and routine clinical practice, as failure to address them adequately can limit treatment response and increase the risk of relapse.

Early, comprehensive, and multidimensional assessment thus becomes the cornerstone of any therapeutic plan: a careful trauma history, specific dissociation and quantification scales for pain, fatigue, and sleep disorders, as well as detailed neuropsychological assessment can quickly identify vulnerable areas and direct the patient to the most appropriate services. In the absence of this early triage, the diagnosis risks remaining fragmented, and the patient caught between specialties, may be left without a clear path to recovery.

In practice, treatment must adapt to each comorbidity profile: from trauma-focused therapies, such as trauma-focused CBT or EMDR, for people with histories marked by adverse events, to multidisciplinary rehabilitation programs that combine graded exercises and cognitive strategies for pain and fatigue management, and to metacognitive interventions and attention and memory training exercises for those affected by functional cognitive disorders. In all these situations, validating symptoms and establishing common goals strengthen the therapeutic alliance and increase adherence to treatment."
 
It doesn't make sense to speak of co-morbidities here, and any notion of "additional symptoms" is entirely artificial on the basis of taking the whole picture, reducing it down to a few bites, declaring it the be-all-and-all explanation, thus leaving a whole lot out. Which they they 'discover', having ignored it in the first place, most of which is consequences of the illness, which they always re-attribute as the cause out of preference .

They try to reduce things to labels that explain everything, which end up explaining nothing but the oddities of the medical profession, then sort of wave off the rest. This is the literal opposite of being holistic. And has zero chance of being useful, but we know this for a fact already.
In practice, treatment must adapt to each comorbidity profile: from trauma-focused therapies, such as trauma-focused CBT or EMDR, for people with histories marked by adverse events, to multidisciplinary rehabilitation programs that combine graded exercises and cognitive strategies for pain and fatigue management, and to metacognitive interventions and attention and memory training exercises for those affected by functional cognitive disorders.
There is literally no evidence for any of this. It's entirely wishcare, what they wish to be true, acting on those beliefs, but decades of studies have shown that none of this makes any difference, clearly is not effective.
 
Back
Top Bottom